One of the HH pathway ligands, Sonic hedgehog (SHH), was expressed by a majority (70%) of pancreatic cancers, while also being present in CSCs of pancreatic ductal adenocarcinoma [48]. Here, SHH is linked to pancreatic neoplasm.